Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Que faire devant une douleur d’amputation?


L’analyse rétrospective du suivi à long terme de 37 amputés de membre est l’occasion d’une revue de la littérature à la fois sur la physiopathologie et le traitement des douleurs d’amputation. Les conséquences morphologiques, neurochimiques et électrophysiologiques de la section nerveuse permettent d’en appréhender les psychophysiologiques et fourmissent des bases théoriques au traitement. Le principal écueil de ces thérapeutiques raisonnablement fondées réside dans leur faible taux de succès à long terme. Ceci débouche sur des considérations concernant la prévention des douleurs et d’éventuelles applications des recherches fondamentales en cours.


The long term follow up of 37 amputees with phantom limb and stump pain gave us an opportunity for reviewing the litterature about pathophysiology and pain relief modalities. The psychophysiological aspects as well as the theoric basis of pain management are well explained by the morphological, neurochemical and electrophysiological consequences of the nerve section. The low long term success rate of all therepeutics constitutes actually their main drawbacks. Thus, prevention of post amputation pain needs much consideration as do forthcoming clinical application of fundamental researches.

This is a preview of subscription content, log in to check access.


  1. 1.

    Loeser J.D.: Pain after amputation: phantom limb and stump pain. In:The management of pain, Bonica J.J., ed. 2nd ed. Lea & Fibiger. Philadelphia, pp. 2444–256, 1990.

  2. 2.

    Melzack R.: Phantom limbs and the concept of neuromatrix.TINS 13, 88–92, 1990.

  3. 3.

    Katz J. andMelzack R.: Pain memories in phantom limb: review and clinical observations.Pain 43, 319–336, 1990.

  4. 4.

    Katz J., Vaccarino A.L., Coderre T.J. andMelzack R.: Injury prior to neurectomy alters the pattern of autotomy in rats.Anesthesiology 75, 876–883, 1991.

  5. 5.

    Guilbaud G., Kayser V. etLombard M.C.: Les différents modèles expérimentaux de la douleur chronique. Intérêt et critiques.In:La douleur et son traitement Jepu A.R., Arnette. Paris, pp. 67–93. 1988.

  6. 6.

    Devor M. andRaber P.: Heritability of symptoms in an experimental model of neuropathic pain.Pain 42, 51–67, 1990.

  7. 7.

    Dudai Y.:The neurobiology of memory. Oxford University Press. Oxford, 1989.

  8. 8.

    Mumenthaler M. andSchliack H.: Histopathological changes in peripheral nerve lesions.In:Peripheral nerve lesions: diagnosis and therapy, Mumenthaler M., Schliack H., eds, Georg Thieme Verlag, Stuttgart, pp. 13–19, 1991.

  9. 9.

    Barde Y.A.: Trophic factors and neuronal survival.Neuron 2, 1525–1534, 1989.

  10. 10.

    Schwartz M., Cohen A., Stein-Izsack C. andBelkin M.: Dichotomy of the glial cell response to axonal injury and regeneration.FASEB 3, 2371–2378, 1989.

  11. 11.

    Kinnman E., Aldskogius H., Weisenfeld-Hallin Z. andJohansson O.: Expansion of sensory innervation after peripheral nerve injury.Pain suppl. 5, S 22, 1990.

  12. 12.

    Xu X.J., Dalsgaard C.J. andWiesenfeld-Hallin Z.: Spinal substance P and NMDA receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex.Neuroscience 51, 641–648, 1992.

  13. 13.

    Seltzer Z., Cohn S., Ginzburg R. andBeilin B.: Modulation of neuropathic pain behaviour in rats by spinal disinhibition and NMDA receptor blockade of injury discharge.Pain 45, 69–75, 1991.

  14. 14.

    Basbaum A.I., Chi S.I. andLevine J.D.: Peripheral and central contribution to persistent expression of the c-fos proto-oncogene in spinal cord after peripheral nerve injury.In:Hyperalgesia and allodynia, Willis W.D., ed., Raven Press, New York, pp. 295–304, 1992.

  15. 15.

    Honken D.B., Battisti W.P., Chesselet M.F., Murray M. andTessier A.: Expression of beta-preprotachykinin mRNA and tachykinins in rat dorsal root ganglion cells following peripheral or central axotomy.Neuroscience 39, 733–742, 1990.

  16. 16.

    Wakisaka S., Kajander K.C. andBennett G.J.: Increased NPY-like immunoreactivity in rat sensory neurons following peripheral axotomy.Neuroscience Letters 124, 200–203, 1991.

  17. 17.

    Besse D.: Les récepteurs opioïdes au niveau des premiers relais médullaires des circuits de la douleur.Lettre de la douleur 18, 7–57, 1992.

  18. 18.

    Baker M. andBostock H.: Ectopic activity in demyelinated spinal root axons of the rat.J. Physiol. 451, 539–552, 1992.

  19. 19.

    Ovelman-Levitt J.: The neurophysiology of deafferentation syndromes.In:Deafferentation pain syndromes: pathophysiology and treatment, Nashold B., Ovelmen-Levitt, J., eds, Raven Press, New York, pp. 103–123, 1991.

  20. 20.

    Titmus M.J. andFaber D.S.: Axotomy induced alterations in the electrophysiological characteristics of neurons.Prog. Neurobiol. 35, 1–51, 1990.

  21. 21.

    Howe J.R., Yaksh T.L. andGo V.L.: The effect of unilateral dorsal root ganglionectomies or ventral thizotomies on alpha 2—adrenoreceptor binding to, and the substance P, enkephalin, and neurotensin content of the cat lumbar spinal cord.Neuroscience 21, 385–394, 1987.

  22. 22.

    Kingery W.S. andVallin J.A.: The development of chronic mechanical hyperalgesia and colleteral sprouting following sciatic nerve section in rat.Pain 38, 321–332, 1989.

  23. 23.

    Ollat H.: Traitement pharmacologique de la douleur neuropathique.Rev. Neurol. 148, 521–531, 1992.

  24. 24.

    Onghena P. andVan Houdenhove B.: Antidepressant induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies.Pain 49, 205–219, 1992.

  25. 25.

    Sawynok J.: GABA-ergic mechanisms of analgesia: an update.Pharmacol. Biochem. Behav. 26, 463–474, 1987.

  26. 26.

    Willow M., Gonoi T., Postme S.W. andCatterall W.A.: Inhibition of voltage-sensitive sodium channels by local anesthetics and anticonvulsivants.In:Molecular and cellular mechanisms of anesthetics, Roth S.H., Miller K.W., eds, Plenum Medical Book Cy, New York, pp. 243–258, 1986.

  27. 27.

    Portenoy R.K.: Pharmacologic management of chronic pain.In:In:Pain syndromes in neurology, Fields H.L., ed., Butterworths, London, pp. 257–278, 1990.

  28. 28.

    Devor M., Govrin-Lippmann R. andRaber P.: Corticosteroids suppress ectopic neuronal discharge originating in experimental neuromas.Pain 22, 127–137, 1985.

  29. 29.

    Burchiel K.J. andRussel L.C.: Glycerol neurolysis: neurophysiological effects of topical glycerol application on rat saphenous nerve.J. Neurosurg. 63, 784–788, 1985.

  30. 30.

    Muller A., Sudbrack G. andLaugner B.: La tolérance aux opiacés existe-t-elle dans le traitement de la douleur chronique?Doul. et Analg. 5, 29–33, 1992.

  31. 31.

    Racle J.P.: Utilisation des alpha-stimulants par voies intrathécale et péridurale.Ann. Fr. Anesth. Réanim. 9, 338–345, 1990.

  32. 32.

    Xu X., Puke M.J.C. andWiesenfeld-Hallin Z.: The depressive effect of intrathecal clonidine on the spinal flexor reflex is enhanced after sciatic nerve section in rats.Pain 51, 145–151, 1992.

  33. 33.

    Glynn C.J., Dawson D. andSanders R.: A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic non cancer pain.Pain 34, 123–128, 1988.

  34. 34.

    Farcot J.M., Mercky F. andGrasser C.: Clonidine par voie épidurale thoraco-lombaire ou sacrée dans les douleurs de déafférantation: possibilités, limites et suivi à long terme.Agressologie 30 139–142, 1989.

  35. 35.

    Roberts W.J. andKramis R.C.: Sympathetic nervous system influence on acute and chronic pain.In:Pain syndromes in neurology, Fields H.L., ed., Butterworths, London, pp. 85–106, 1990.

  36. 36.

    Campbell J.N., Meyer R.A., Davis K.D. andRaja S.N.: Sympathetically maintained pain: a unifying hypothesis.In:Hyperalgesia and allodynia Willis W., ed., Raven Press, New York, pp. 141–149, 1992.

  37. 37.

    Mannheimer J.S. andLampe G.N.:Clinical transcutaneous electrical nerve stimulation. F.A. Davis Company, Philadelphia, 1986.

  38. 38.

    Meyerson B.A.: Electrical stimulation of the spinal cord and brain.In:The management of pain, Bonica J.J., ed., Lee & Fibiger, Philadelphia, 1990.

  39. 39.

    Tyrer S.P.:Psychology, psychiatry and chronic pain. Butterworth, Heinemann, 1992.

  40. 40.

    Bach S., Noreng M.E. andTjellden N.O.: Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumbar epidural block.Pain 33, 297–301, 1988.

  41. 41.

    Fisher A. andMeller Y.: Continuous postoperative analgesia by nerve sheath block for amputation surgery.Anesth. Analg., 72, 300–303, 1991.

  42. 42.

    Jaeger H. andMaier C.: Calcitonin in phantom limb pain: a doubleblind study.Pain 48, 21–27, 1992.

  43. 43.

    Yamamoto T. andYaksh T.L.: Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagoniats.Pain 49, 121–128, 1992.

  44. 44.

    Kristensen J.D., Svensson B. andGordh T.: The NMDA-receptor antagonist CPP abolishes neurogenic «wind-up pain» after intrathecal administration in humans.Pain 51 249–253, 1992.

Download references

Author information

Correspondence to A. Muller.

Additional information

Texte présenté lors du Congrès de la SOFRED des 8 et 9 octobre 1992.

About this article

Cite this article

Muller, A. Que faire devant une douleur d’amputation?. Doul. et Analg. 6, 41 (1993).

Download citation

Key words

  • Phantom pain
  • stump pain